Chang Tm
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
-
- Hemoglobin structure and function
Papers in
-
- Metabolism and Genetic Disorders 6
-
- Blood donation and transfusion practices 3
- Journals
- The International Journal of Artificial Organs (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (33 papers)
- Partner nations
- Canada
In The Last Decade
Chang Tm
34 papers receiving 430 citations
Peers
Comparison fields: 5 of 74
- Hepatology 79
- Cell Biology 82
- Nephrology 30
- Surgery 171
- Pharmacology 33
Countries citing papers authored by Chang Tm
This map shows the geographic impact of Chang Tm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Tm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Tm more than expected).
Fields of papers citing papers by Chang Tm
This network shows the impact of papers produced by Chang Tm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Tm. The network helps show where Chang Tm may publish in the future.
Co-authorship network
The 11 scholars most cited alongside Chang Tm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. | 1990 | 51 |
| 2 | Conversion of ammonia or urea into L-leucine, L-valine, and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD+. Glucose dehydrogenase for co-factor recycling. | 1988 | 6 |
| 3 | Artificial liver support: requirements and approaches. | 1983 | 5 |
| 4 | In vivo assessment of pyridoxylated crosslinked polyhemoglobin as an artificial red cell substitute in rats. | 1983 | 24 |
| 5 | Phase one clinical trial of a new composite artificial kidney: a single unit combining dialysis with hemoperfusion. | 1982 | 9 |
| 6 | Effects of temperature on the removal of urea as ammonia by enzymatic conversion and by gas absorption using an oxygenator. | 1981 | 0 |
| 7 | Lipid-nylon membrane artificial cells containing multienzyme systems, cofactors and substrates for the sequential conversion of ammonia and urea into glutamate. | 1981 | 7 |
| 8 | Blood compatible coating of synthetic immunoadsorbents. | 1980 | 16 |
| 9 | Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. | 1980 | 18 |
| 10 | Artificial red blood cells. | 1980 | 10 |
| 11 | Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. | 1978 | 29 |
| 12 | Artificial cells in 1977. | 1978 | 1 |
| 13 | Coated charcoal hemoperfusion for the removal galactose in rats. | 1978 | 2 |
| 14 | Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. | 1976 | 76 |
| 15 | Microcapsule artificial kidney: including updated preparative procedures and properties. | 1976 | 19 |
| 16 | Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. | 1976 | 20 |
| 17 | Clincial performance characteristics of a new combined system for simulatenous hemoperfusion-hemodialysis-ultrafiltration in series. | 1975 | 21 |
| 18 | Biomedical applications of artificial cells. | 1973 | 7 |
| 19 | Immobilization of enzymes, adsorbents, or both within semipermeable microcapsules (artificial cells) for clinical and experimental treatment of metabolite-related disorders. | 1973 | 3 |
| 20 | Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal. | 1971 | 27 |
About Chang Tm
Chang Tm is a scholar working on Clinical Biochemistry, Management of Technology and Innovation, Critical Care and Intensive Care Medicine, Transplantation and Biochemistry, having authored 35 papers that have together received 472 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), Enzyme Catalysis and Immobilization (4 papers), Organ Donation and Transplantation (3 papers), Pancreatic function and diabetes (3 papers), Blood donation and transfusion practices (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Erythrocyte Function and Pathophysiology (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (79 citations), Cell Biology (82 citations), Nephrology (30 citations), Surgery (171 citations) and Pharmacology (33 citations). Chang Tm has collaborated with scholars based in Canada. Frequent co-authors include C. Lister, A. Gonda, C W Cole, Martha Farmer, S. Sideman, Sujith Kuruvilla, Paul E. Barré, G Moss, Róbert Langer and Perry J. Blackshear. Their work appears in journals such as The International Journal of Artificial Organs, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.